We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKYY icon
1776
First Trust Cloud Computing ETF
SKYY
$2.82B
$17K ﹤0.01%
284
WIW
1777
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$507M
$17K ﹤0.01%
1,500
PRSU
1778
Pursuit Attractions and Hospitality Inc
PRSU
$1.48B
$17K ﹤0.01%
259
+60
+30% +$3.89K
TGP
1779
DELISTED
Teekay LNG Partners L.P.
TGP
$17K ﹤0.01%
1,113
SOJA
1780
DELISTED
The Southern Company Series 2015A 6.25% Junior Subordinated Notes due October 15, 2075
SOJA
$17K ﹤0.01%
650
BKH icon
1781
Black Hills Corp
BKH
$5.69B
$16K ﹤0.01%
206
+31
+18% +$2.39K
BOKF icon
1782
BOK Financial
BOKF
$8.65B
$16K ﹤0.01%
184
DIN icon
1783
Dine Brands
DIN
$458M
$16K ﹤0.01%
193
+46
+31% +$3.57K
EQT icon
1784
EQT Corp
EQT
$32.3B
$16K ﹤0.01%
1,577
-275
-15% -$2.69K
ESLT icon
1785
Elbit Systems
ESLT
$38.4B
$16K ﹤0.01%
105
+10
+11% +$1.63K
FR icon
1786
First Industrial Realty Trust
FR
$8.77B
$16K ﹤0.01%
388
HEI icon
1787
HEICO Corp
HEI
$50.8B
$16K ﹤0.01%
141
+8
+6% +$985
HL icon
1788
Hecla Mining
HL
$9.76B
$16K ﹤0.01%
5,000
-1,467
-23% -$3.6K
IWL icon
1789
iShares Russell Top 200 ETF
IWL
$2.16B
$16K ﹤0.01%
226
NDSN icon
1790
Nordson
NDSN
$16.9B
$16K ﹤0.01%
103
+52
+102% +$8.21K
ODP
1791
DELISTED
ODP
ODP
$16K ﹤0.01%
592
+114
+24% +$2.54K
SNBR
1792
DELISTED
Sleep Number
SNBR
$16K ﹤0.01%
330
+82
+33% +$3.9K
SXI icon
1793
Standex International
SXI
$3.56B
$16K ﹤0.01%
206
+93
+82% +$7.07K
TBI
1794
Trueblue
TBI
$235M
$16K ﹤0.01%
679
+192
+39% +$4.38K
XNCR icon
1795
Xencor
XNCR
$1.48B
$16K ﹤0.01%
493
+154
+45% +$5.63K
HA
1796
DELISTED
Hawaiian Holdings, Inc.
HA
$16K ﹤0.01%
579
+322
+125% +$9.41K
CHIC
1797
DELISTED
Global X MSCI China Communication Services ETF
CHIC
$16K ﹤0.01%
660
ZEN
1798
DELISTED
ZENDESK INC
ZEN
$16K ﹤0.01%
210
+20
+11% +$1.47K
MNTA
1799
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$16K ﹤0.01%
861
+140
+19% +$2.24K
VSTO
1800
DELISTED
Vista Outdoor Inc.
VSTO
$16K ﹤0.01%
2,298
+97
+4% +$728

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.